Neurodegeneration in Newborns After Anesthetics
Completed
Conditions studied: Neurodegeneration, General Anesthesia
In brief
The purpose of the study is to quantify biomarkers of neural damage in neonates exposed to varying levels of volatile anesthetic in utero.
Key facts
- Study ID
- NCT03064607
- Run by
- University of Pennsylvania
- People needed
- 25
- Starts
- 2010-11-05
- Expected to finish
- 2018-02-06
- Last updated by the study team
- 2019-02-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women delivering a child via cesarean section or EXIT procedure
- Informed consent
You may not qualify if…
- Known fetal neurologic defect
- Known maternal neurologic abnormality
- Sensitivity or allergy to medications used in the study
- C-section under epidural anesthesia: induction and maintenance with 1.5% lidocaine, sodium bicarbonate and 1:200,000 epinephrine
- C-section under general anesthesia: induction with propofol 2 mg/kg and succinylcholine 2 mg/kg intravenously; maintenance with desflurane 4.5-5%
- EXIT procedure under general anesthesia: induction with propofol 2 mg/kg and succinylcholine 2 mg/kg intravenously; maintenance with desflurane 15-18%
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.